481 related articles for article (PubMed ID: 31862399)
1. Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.
Das NA; Carpenter AJ; Belenchia A; Aroor AR; Noda M; Siebenlist U; Chandrasekar B; DeMarco VG
Cell Signal; 2020 Apr; 68():109506. PubMed ID: 31862399
[TBL] [Abstract][Full Text] [Related]
2. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
[TBL] [Abstract][Full Text] [Related]
3. RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferation.
Mummidi S; Das NA; Carpenter AJ; Yoshida T; Yariswamy M; Mostany R; Izadpanah R; Higashi Y; Sukhanov S; Noda M; Siebenlist U; Rector RS; Chandrasekar B
J Cell Physiol; 2019 Dec; 234(12):22242-22259. PubMed ID: 31074012
[TBL] [Abstract][Full Text] [Related]
4. Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
Panchapakesan U; Pegg K; Gross S; Komala MG; Mudaliar H; Forbes J; Pollock C; Mather A
PLoS One; 2013; 8(2):e54442. PubMed ID: 23390498
[TBL] [Abstract][Full Text] [Related]
5. The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.
Sukhanov S; Higashi Y; Yoshida T; Mummidi S; Aroor AR; Jeffrey Russell J; Bender SB; DeMarco VG; Chandrasekar B
Cell Signal; 2021 Jan; 77():109825. PubMed ID: 33160017
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration.
Siddesha JM; Valente AJ; Yoshida T; Sakamuri SS; Delafontaine P; Iba H; Noda M; Chandrasekar B
Cell Signal; 2014 May; 26(5):933-41. PubMed ID: 24447911
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.
Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B
J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877
[TBL] [Abstract][Full Text] [Related]
8. No Cytotoxic and Inflammatory Effects of Empagliflozin and Dapagliflozin on Primary Renal Proximal Tubular Epithelial Cells under Diabetic Conditions In Vitro.
Baer PC; Koch B; Freitag J; Schubert R; Geiger H
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936266
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration.
Chandrasekar B; Mummidi S; DeMarco VG; Higashi Y
Mediators Inflamm; 2023; 2023():6112301. PubMed ID: 37830075
[TBL] [Abstract][Full Text] [Related]
10. Tofogliflozin, A Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation.
Ishibashi Y; Matsui T; Yamagishi S
Horm Metab Res; 2016 Mar; 48(3):191-5. PubMed ID: 26158396
[TBL] [Abstract][Full Text] [Related]
11. Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules.
Li J; Liu H; Takagi S; Nitta K; Kitada M; Srivastava SP; Takagaki Y; Kanasaki K; Koya D
JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32134397
[TBL] [Abstract][Full Text] [Related]
12. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
[TBL] [Abstract][Full Text] [Related]
13. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
[TBL] [Abstract][Full Text] [Related]
15. Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration by reversing miR-221- and -222-mediated RECK suppression.
Higashi Y; Mummidi S; Sukhanov S; Yoshida T; Noda M; Delafontaine P; Chandrasekar B
Cell Signal; 2019 May; 57():10-20. PubMed ID: 30716386
[TBL] [Abstract][Full Text] [Related]
16. Effect of zinc on high glucose-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells.
Zhang X; Liang D; Chi ZH; Chu Q; Zhao C; Ma RZ; Zhao Y; Li H
Int J Mol Med; 2015 Jun; 35(6):1747-54. PubMed ID: 25872526
[TBL] [Abstract][Full Text] [Related]
17. High glucose-induced Smad3 linker phosphorylation and CCN2 expression are inhibited by dapagliflozin in a diabetic tubule epithelial cell model.
Pan X; Phanish MK; Baines DL; Dockrell MEC
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34003249
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.
Terami N; Ogawa D; Tachibana H; Hatanaka T; Wada J; Nakatsuka A; Eguchi J; Horiguchi CS; Nishii N; Yamada H; Takei K; Makino H
PLoS One; 2014; 9(6):e100777. PubMed ID: 24960177
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4/NF-κB signaling pathway in human renal tubular epithelial cells.
Su J; Ren J; Chen H; Liu B
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32073611
[TBL] [Abstract][Full Text] [Related]
20. Scopoletin alleviates high glucose-induced toxicity in human renal proximal tubular cells via inhibition of oxidative damage, epithelial-mesenchymal transition, and fibrogenesis.
Kundu S; Ghosh S; Sahu BD
Mol Biol Rep; 2024 May; 51(1):620. PubMed ID: 38709349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
